Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Neurology

Neuro/Psych pharmacology

Natalizumab vs fingolimod for patients with active relapsing-remitting multiple sclerosis: Results from REVEAL, a prospective, randomised head-to-head study

BMJ Open | Oct 23, 2020 Neuro/Psych pharmacology

Lorazepam timing for acute convulsive seizure control (LoTASC)

Seizure - European Journal of Epilepsy | Oct 09, 2020 Neuro/Psych pharmacology

Capecitabine-temozolomide (CAPTEM) in advanced grade 2 and grade 3 neuroendocrine neoplasms (NENs) – benefits of chemotherapy in NENs with significant 18FDG uptake

Neuroendocrinology | Oct 08, 2020 Neuro/Psych pharmacology

Assessing safety of direct thrombin inhibitors, direct factor Xa inhibitors and vitamin K antagonists in patients with atrial fibrillation: A nation-wide propensity score matched cohort from Sweden

Clinical Epidemiology | Oct 08, 2020 Neuro/Psych pharmacology

Intravenous chlorpromazine as potentially useful treatment for chronic headache disorders

Headache: The Journal of Head and Face Pain | Sep 30, 2020 Neuro/Psych pharmacology

Varenicline for the treatment of postural and gait dysfunction in Parkinson disease (PD)

Neurology® Clinical Practice | Sep 28, 2020 Neuro/Psych pharmacology

Plasma D‐dimer concentrations predicting stroke risk and rivaroxaban benefit in patients with heart failure and sinus rhythm: An analysis from the COMMANDER‐HF trial

European Journal of Heart Failure | Sep 27, 2020 Neuro/Psych pharmacology

Effect of clopidogrel and aspirin vs aspirin alone on migraine headaches after transcatheter atrial septal defect closure: One-year results of the CANOA randomized clinical trial

JAMA | Sep 26, 2020 Neuro/Psych pharmacology

The treatment effect on peripheral B cell markers in antibody positive myasthenia gravis patients

Journal of Neuroimmunology | Sep 25, 2020 Neuro/Psych pharmacology

Safety, efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and Alzheimer disease dementia: A randomized clinical trial

JAMA | Sep 18, 2020 Neuro/Psych pharmacology

« Prev 1 … 8 9 10 11 12 … 72 Next »

Natalizumab vs fingolimod for patients with active relapsing-remitting multiple sclerosis: Results from REVEAL, a prospective, randomised head-to-head study

Lorazepam timing for acute convulsive seizure control (LoTASC)

Capecitabine-temozolomide (CAPTEM) in advanced grade 2 and grade 3 neuroendocrine neoplasms (NENs) – benefits of chemotherapy in NENs with significant 18FDG uptake

Assessing safety of direct thrombin inhibitors, direct factor Xa inhibitors and vitamin K antagonists in patients with atrial fibrillation: A nation-wide propensity score matched cohort from Sweden

Intravenous chlorpromazine as potentially useful treatment for chronic headache disorders

Varenicline for the treatment of postural and gait dysfunction in Parkinson disease (PD)

Plasma D‐dimer concentrations predicting stroke risk and rivaroxaban benefit in patients with heart failure and sinus rhythm: An analysis from the COMMANDER‐HF trial

Effect of clopidogrel and aspirin vs aspirin alone on migraine headaches after transcatheter atrial septal defect closure: One-year results of the CANOA randomized clinical trial

The treatment effect on peripheral B cell markers in antibody positive myasthenia gravis patients

Safety, efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and Alzheimer disease dementia: A randomized clinical trial

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Pulmonary Embolism: MCQs Challenge

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

Top Foods to Combat Winter Illness

Natalizumab vs fingolimod for patients with active relapsing-remitting multiple sclerosis: Results from REVEAL, a prospective, randomised head-to-head study

Lorazepam timing for acute convulsive seizure control (LoTASC)

Capecitabine-temozolomide (CAPTEM) in advanced grade 2 and grade 3 neuroendocrine neoplasms (NENs) – benefits of chemotherapy in NENs with significant 18FDG uptake

Assessing safety of direct thrombin inhibitors, direct factor Xa inhibitors and vitamin K antagonists in patients with atrial fibrillation: A nation-wide propensity score matched cohort from Sweden

Intravenous chlorpromazine as potentially useful treatment for chronic headache disorders

Varenicline for the treatment of postural and gait dysfunction in Parkinson disease (PD)

Plasma D‐dimer concentrations predicting stroke risk and rivaroxaban benefit in patients with heart failure and sinus rhythm: An analysis from the COMMANDER‐HF trial

Effect of clopidogrel and aspirin vs aspirin alone on migraine headaches after transcatheter atrial septal defect closure: One-year results of the CANOA randomized clinical trial

The treatment effect on peripheral B cell markers in antibody positive myasthenia gravis patients

Safety, efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and Alzheimer disease dementia: A randomized clinical trial

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Pulmonary Embolism: MCQs Challenge

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

Top Foods to Combat Winter Illness

Select Specialty

Select Topic